Showing results (41-50 of 705) with videos related to

Sort By:
Pageof 71
Circulation. Arrhythmia and Electrophysiology|July 14, 2018
Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities)Liping Mou, Faye L Norby, Lin Y Chen, et al.
British Journal of Haematology|March 29, 2019
Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolismPamela L Lutsey, Neil A Zakai, Richard F MacLehose, et al.
Stroke|October 19, 2019
Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC StudyJoseph J Decker, Faye L Norby, Mary R Rooney, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 11, 2021
Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare BeneficiariesFaye L Norby, Pamela L Lutsey, Nathan D Shippee, et al.
BMC Cardiovascular Disorders|September 7, 2017
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillationFaye L Norby, Lindsay G S Bengtson, Pamela L Lutsey, et al.
Research and Practice in Thrombosis and Haemostasis|March 27, 2023
Autoimmune disease and risk of postpartum venous thromboembolismRob F Walker, Neil A Zakai, Susan M Mason, et al.
Stroke|March 19, 2019
Association of Atrial Fibrillation With White Matter DiseaseIris Yuefan Shao, Melinda C Power, Thomas Mosley, et al.
Pageof 71